Perrigo Reports First Quarter 2021 Financial Results From Continuing Operations

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. QGEN
10. SPY

Go back to Perrigo Reports First Quarter 2021 Financial Results From Continuing Operations

Perrigo (PRGO) Misses Q1 EPS by 7c, Revenues Miss; Offers FY21 EPS Mid-Point Guidance Above Consensus

May 11, 2021 6:32 AM EDT

Perrigo (NYSE: PRGO) reported Q1 EPS of $0.50, $0.07 worse than the analyst estimate of $0.57. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $1.02 billion.

President and CEO, Murray S. Kessler commented, "Two years ago, we began our journey to transform Perrigo from a healthcare to a consumer self-care company and with the actions taken this quarter, that transformation is now nearly complete. On March 1, 2021, we announced the divestment of our generic Rx business, our tenth transaction over the last two years, essentially completing our portfolio reconfiguration. We have made the necessary... More